EMulate Therapeutics Announces Issuance Of 41st Patent Covering The Design Of A Pediatric Therapeutic Device For Cancer And Other Health Indications

Written By Kyle Kingma
Kyle Kingma
Previous

The Age of Digital Therapeutics is Upon Us: EMulate Therapeutics, Inc.
Next

EMulate Therapeutics Announces the Incorporation of a Third Wholly Owned Subsidiary